The lead and the icd were returned and subjected to an extensive analysis.The lead was inspected visually, electrically, and mechanically.During this inspection, no deviations from the technical specifications were found that could be linked to the clinical complaint.The lead was to specifications and in working order.The returned icd was status interrogated.The device status was bos and three charging processes were documented in the device's memory.In the next step, the icds ability to deliver therapy and its power consumption were examined.The antibradycardia output signal was in working order and in accordance with the values programmed.A fibrillation signal was applied and the device reacted as per specifications with a defibrillation shock.The specified energy level was attained and the charging time for the defibrillation shock was normal and as expected.The examination of the icd power consumption showed intermittently slightly elevated values.An additional test of the impedance measurement functions showed nothing unusual.The impedance measurement functions behaved without incident during testing.After these steps, the icd was opened to conduct a visual and electrical analysis of the electronic module.We do not yet have the results from this analysis.As soon as the icd analysis has been completed, the update will be updated and shared with reference to inlexa 3 hf-t qp df4 is4 (sn 60906395).
|